Literature DB >> 19241137

Postnatal assessment of growth, nutrition, and urinary tract infections of infants with antenatally detected hydronephrosis.

Onder Yavascan1, Nejat Aksu, Murat Anil, Orhan D Kara, Yahya Aydin, Murat Kangin, Ergun Cetinkaya, Alkan Bal.   

Abstract

The widespread utilization of prenatal ultrasonography and the detection of antenatal hydronephrosis (AH) have raised the importance of postnatal follow-up of these infants. In this study, we aimed to determine the importance of an early diagnosis for the treatment of urinary tract malformations (UTM) as well as the postnatal evaluation of growth and nutrition status and the frequency of urinary tract infection (UTI) in infants with AH. We evaluated 246 infants (183 boys, 63 girls) whose routine antenatal scans showed an anterior-posterior pelvic diameter (APPD) ≥5 mm. Of the 246 patients, 175 (71.1%) were found to be pathological and 71 were evaluated as normal after the follow-up period. The median follow-up periods of normal and abnormal cases were 45.7 and 43.4 months, respectively. All cases with or without UTM were evaluated in terms of UTI, scars on DMSA, growth [Height Z score (HZ), Weight Z score (WZ)] and nutrition [Weight height index (WHI)] status. The annual UTI frequency was higher in cases with UTM (1.32 ± 1.66 episode/year) than in cases without abnormality (0.27 ± 0.67 episode/year) (P < 0.001). The postnatal evaluation of growth and nutritional status in children with UTM (mean WHI, HZ, and WZ scores: 96.82 ± 10.21, 0.03 ± 0.54 and 0.04 ± 0.61, respectively) was found to be significantly worse than in cases without abnormality (102.25 ± 9.84, 0.14 ± 0.64 and 0.24 ± 0.76, respectively), (P < 0.05). In abnormal patients, the mean WHI, HZ, and WZ were significantly improved to 101.63 ± 9.75, 0.26 ± 1.07, and 0.28 ± 0.98, respectively, and HZ or WZ scores were found to be similar when compared to normals. In conclusion, postnatal early management of infants with AH seems to prevent frequent UTIs and nutritional disturbances enabling normal growth.

Entities:  

Mesh:

Year:  2009        PMID: 19241137     DOI: 10.1007/s11255-009-9530-4

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  31 in total

1.  Can careful ultrasound examination of the urinary tract exclude vesicoureteric reflux in the neonate?

Authors:  E F Avni; K Ayadi; F Rypens; M Hall; C C Schulman
Journal:  Br J Radiol       Date:  1997-10       Impact factor: 3.039

Review 2.  Urinary tract infection in children: a review of its pathogenesis and risk factors.

Authors:  M Twaij
Journal:  J R Soc Promot Health       Date:  2000-12

3.  Clinical relevance and implications of antenatal hydronephrosis.

Authors:  J A Dudley; J M Haworth; M E McGraw; J D Frank; E J Tizard
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-01       Impact factor: 5.747

4.  Increased sodium requirement following early postnatal surgical correction of congenital uropathies in infants.

Authors:  F Terzi; B M Assael; A Claris-Appiani; G Marra; C A Dell'Agnola; B Tadini; V Tomaselli
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

5.  The outcome of stopping prophylactic antibiotics in older children with vesicoureteral reflux.

Authors:  C S Cooper; B I Chung; A J Kirsch; D A Canning; H M Snyder
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

6.  Body growth in early diagnosed vesicoureteric reflux.

Authors:  C Polito; A La Manna; L Mansi; P F Rambaldi; M R Papale; A Marte; R Di Toro
Journal:  Pediatr Nephrol       Date:  1999-11       Impact factor: 3.714

7.  Relationship between acute pyelonephritis, renal scarring, and vesicoureteral reflux. Results of a coordinated research project.

Authors:  Pilar Orellana; Paulina Baquedano; Venkatesh Rangarajan; Jin Hua Zhao; Ng David Chee Eng; Jurij Fettich; Tawatchi Chaiwatanarat; Kerim Sonmezoglu; Dilip Kumar; Yung Ha Park; Aban Meyer Samuel; Rune Sixt; Veereshwar Bhatnagar; Ajit K Padhy
Journal:  Pediatr Nephrol       Date:  2004-07-16       Impact factor: 3.714

8.  Renal tubular acidosis in children with vesicoureteral reflux.

Authors:  J M Guizar; C Kornhauser; J M Malacara; G Sanchez; J Zamora
Journal:  J Urol       Date:  1996-07       Impact factor: 7.450

9.  Medical treatment of vesicoureteral reflux detected in infancy.

Authors:  A B Pintér; V Jászai; I Dóber
Journal:  J Urol       Date:  1988-07       Impact factor: 7.450

10.  Results of surgical treatment of severe vesicoureteric reflux. Retrospective study of reflux grades 4 and 5.

Authors:  H Jansen; R J Scholtmeijer
Journal:  Br J Urol       Date:  1990-04
View more
  6 in total

1.  Probability of urinary tract infection in infants with ureteropelvic junction obstruction: is antibacterial prophylaxis really needed?

Authors:  Ali Islek; Ayfer Gür Güven; Mustafa Koyun; Sema Akman; Emel Alimoglu
Journal:  Pediatr Nephrol       Date:  2011-04-26       Impact factor: 3.714

Review 2.  Current management of antenatal hydronephrosis.

Authors:  Kleiton G R Yamaçake; Hiep T Nguyen
Journal:  Pediatr Nephrol       Date:  2012-07-27       Impact factor: 3.714

3.  Significance of Postnatal Follow-up of Infants with Vesicoureteral Reflux Having Antenatal Hydronephrosis.

Authors:  Murat Kangin; Nejat Aksu; Onder Yavascan; Murat Anil; Orhan Deniz Kara; Alkan Bal; Fulya Kamit
Journal:  Iran J Pediatr       Date:  2010-12       Impact factor: 0.364

4.  Incidence and outcomes of antenatally detected congenital hydronephrosis.

Authors:  Jameela Abdulaziz Kari; Saddiq Habiballah; Saad A Alsaedi; Hussain Alsaggaf; Amal Al-dabbagh; Adila AbulHamail; Adel Marzouki; Basem Eldeek
Journal:  Ann Saudi Med       Date:  2013 May-Jun       Impact factor: 1.526

5.  Revised guidelines on management of antenatal hydronephrosis.

Authors:  A Sinha; A Bagga; A Krishna; M Bajpai; M Srinivas; R Uppal; I Agarwal
Journal:  Indian J Nephrol       Date:  2013-03

6.  From Research Question to Conducting a Randomized Controlled Trial on Continuous Antibiotic Prophylaxis in Prenatal Hydronephrosis: A Rational Stepwise Process.

Authors:  Luis H Braga; Bethany Easterbrook; Kizanee Jegatheeswaran; Armando J Lorenzo
Journal:  Front Pediatr       Date:  2016-03-30       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.